# US 2013/0158518 A1 · Surface modification for catheters comprised of multiple materials

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2013/0158518 A1
- Document ID: US20130158518A1
- Status: Published application
- Kind: A1
- Application number: 13/715,095
- Filed: 2012-12-14
- Published: 2013-06-20
- Earliest claimed: 2011-12-14
- Assignees: Semprus Biosciences Corp.
- Inventors: Jun LI; Zheng ZHANG; Douglas WEAVER; Eric W. MARCHESE; Abby N. DELEAULT; Phu C. NGUYEN; Kobe ELIAS; Chad HUVAL; Christopher R. LOOSE
- Web page: https://patentgrep.com/patent/US20130158518A1

## CPC

- A61M 25/0045: {multi-layered, e.g. coated (coating materials A61L29/08)}
- A61L 29/049: {Mixtures of macromolecular compounds}
- A61L 29/085: {Macromolecular materials}
- A61L 29/14: Materials characterised by their function or physical properties {, e.g. lubricating compositions}
- A61L 29/18: Materials at least partially X-ray or laser opaque
- A61L 33/0023: {using a quaternized group or a protonated amine group of the substrate}
- A61L 33/064: {obtained by reactions only involving carbon-to-carbon unsaturated bonds (A61L33/062 takes precedence)}
- A61M 25/00: Catheters; Hollow probes (dilators A61M29/00; {peritoneal catheters A61M1/285; tracheal tubes A61M16/04; for drainage A61M27/00; for uterus, vagina or rectum A61M31/00} ; for measuring or testing A61B; {materials for catheters A61L29/00})
- A61M 25/0012: {with embedded structures, e.g. coils, braids, meshes, strands or radiopaque coils}
- A61L 2400/12: Nanosized materials, e.g. nanofibres, nanoparticles, nanowires, nanotubes; Nanostructured surfaces
- A61M 2025/0019: {Cleaning catheters or the like, e.g. for reuse of the device, for avoiding replacement}
- A61M 2025/0042: {Microcatheters, cannula or the like having outside diameters around 1 mm or less}
- A61M 2025/0046: {Coatings for improving slidability}
- A61M 2025/0047: {the inner layer having a higher lubricity}
- A61M 2025/0062: {having features to improve the sliding of one part within another by using lubricants or surfaces with low friction}
- Y10T 428/1393: Multilayer [continuous layer]
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- Y10T: TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION

## Abstract

Catheters and a method for preparation thereof, the catheter comprising as component parts thereof a catheter body, a juncture hub, at least one extension line and at least one connector, each of said component parts comprising an exterior surface, at least one lumen having an intraluminal surface and a bulk polymer, wherein the intraluminal or external surface of a first of said component parts and the exterior or intraluminal surface of a second of said component parts comprise a hydrophilic polymer layer thereon having an Average Dry Thickness of at least about 50 nanometers and the first and second component parts comprise bulk polymers having different chemical compositions

## Claims

### Claim 1

A catheter comprising as component parts thereof a catheter body, a juncture hub, at least one extension line and at least one connector, each of said component parts comprising an exterior surface, at least one lumen having an intraluminal surface and a bulk polymer, wherein the intraluminal or external surface of a first of said component parts and the exterior or intraluminal surface of a second of said component parts comprise a hydrophilic polymer layer thereon having an Average Dry Thickness of at least about 50 nanometers and the first and second component parts comprise bulk polymers having different chemical compositions.

### Claim 2 (depends on 1)

The catheter of claim 1 wherein at least one catheter body lumen has an aspect ratio of at least 3:1 and an intraluminal surface comprising a hydrophilic polymer layer thereon, the hydrophilic polymer layer on said at least one catheter body lumen having an Average Dry Thickness of at least about 50 nanometers.

### Claim 3 (depends on 1)

The catheter of claim 1 wherein at least one catheter body lumen has an aspect ratio of at least 3:1 and an intraluminal surface comprising a hydrophilic polymer layer thereon, the hydrophilic polymer layer on said at least one catheter body lumen having an Average Dry Thickness of at least about 50 nanometers and comprising repeat units, at least 30% of which are derived from a hydrophilic monomer.

### Claim 4 (depends on 1)

The catheter of claim 1 wherein at least one catheter body lumen has an aspect ratio of at least 3:1 and an intraluminal surface comprising a hydrophilic polymer layer thereon, the hydrophilic polymer layer on said at least one catheter body lumen having an Average Dry Thickness of at least about 50 nanometers and a standard deviation of the Average Dry Thickness that does not exceed 100% of the Average Dry Thickness of the hydrophilic polymer layer.

### Claim 5 (depends on 1)

The catheter of claim 1 wherein at least one catheter body lumen has an aspect ratio of at least 3:1 and an intraluminal surface comprising a hydrophilic polymer layer thereon, the hydrophilic polymer layer on said at least one catheter body lumen having an Average Dry Thickness of at least about 50 nanometers, the hydrophilic polymer layer on said at least one catheter body lumen being conformal at a level of 1 mm2.

### Claim 6 (depends on 1)

The catheter of claim 1 wherein at least one catheter body lumen has an aspect ratio of at least 3:1, an intraluminal surface having a global average Rrms surface roughness and comprising a hydrophilic polymer layer thereon, the hydrophilic polymer layer on said at least one catheter body lumen having an Average Dry Thickness that exceeds the global average Rrms surface roughness of the intraluminal surface and is at least about 50 nm.

### Claim 7 (depends on 1)

The catheter of claim 1 wherein at least one catheter body lumen has an aspect ratio of at least 3:1, an intraluminal surface having a global average Rrms surface roughness and comprising a hydrophilic polymer layer thereon, the hydrophilic polymer layer on said at least one catheter body lumen having an Average Dry Thickness that is at least about 50 nm, the intraluminal surface and the hydrophilic polymer layer, in combination, constituting a modified surface having a global average Rrms surface roughness that is less than the global average Rrms surface roughness of the intraluminal surface.

### Claim 8 (depends on 1)

The catheter of claim 1 wherein at least one catheter body lumen has an aspect ratio of at least 3:1, an intraluminal surface having a global average Rrms surface roughness and comprising a hydrophilic polymer layer thereon, the hydrophilic polymer layer on said at least one catheter body lumen having an Average Dry Thickness that is at least about 50 nm, the intraluminal surface and the hydrophilic polymer layer, in combination, constituting a modified surface having a fibrinogen adsorption of less than about 125 ng/cm2 in a fibrinogen binding assay in which the modified surface is incubated for 60 minutes at 37° C. in a composition containing 70 μg/ml fibrinogen derived from human plasma and 1.4 μg/ml I-125 radiolabeled fibrinogen.

### Claim 9 (depends on 1)

The catheter of claim 1 wherein at least one lumen of the catheter body, juncture hub, extension line or connecter has an aspect ratio of at least 5:1 and an intraluminal surface comprising a hydrophilic polymer layer thereon having a thickness of at least about 50 nm.

### Claim 10 (depends on 1)

The catheter of claim 1 wherein at least one lumen of the catheter body, juncture hub, extension line or connecter has an aspect ratio of at least 1,000:1 and an intraluminal surface comprising a hydrophilic polymer layer thereon having a thickness of at least about 50 nm.

### Claim 11 (depends on 1)

The catheter of claim 1 wherein at least one lumen of the catheter body, juncture hub, extension line or connecter has a proximal end, a distal end, a Midpoint Region located between 40% and 60% of the distance between the proximal and distal ends and an intraluminal surface comprising a hydrophilic polymer layer thereon having a thickness of at least about 50 nm in the Midpoint Region.

### Claim 12 (depends on 1)

The catheter of claim 1 wherein at least one lumen of the catheter body, juncture hub, extension line or connecter has a proximal end, a distal end, a Midpoint Region located between 40% and 60% of the distance between the proximal and distal ends and an intraluminal surface comprising a hydrophilic polymer layer thereon having a thickness of at least about 1,000 nm in the Midpoint Region.

### Claim 13 (depends on 1)

The catheter of claim 1 wherein the catheter body has a proximal end, a distal end and a tip region having a length of 5 cm measured from the distal end of the catheter body, and a hydrophilic polymer layer having a thickness of at least about 50 nm on the exterior surface of the catheter body in the tip region or on an intraluminal surface of at least one lumen comprised by the catheter body in the tip region.

### Claim 14 (depends on 1)

The catheter of claim 1 wherein the catheter body has a proximal end, a distal end and a tip region having a length of 5 cm measured from the distal end of the catheter body, and a hydrophilic polymer layer having a thickness of at least about 1,000 nm on the exterior surface of the catheter body in the tip region or on an intraluminal surface of at least one lumen comprised by the catheter body in the tip region,

### Claim 15 (depends on 1)

The catheter of claim 1 wherein the hydrophilic polymer layer on the exterior surface of the catheter body in the tip region or on at least one intraluminal surface of a lumen comprised by the catheter body in the tip region is conformal at a level of 0.5 mm2.

### Claim 16 (depends on 1)

The catheter of claim 1 wherein the hydrophilic polymer layer on at least one intraluminal surface of a lumen comprised by the catheter body, juncture hub, extension line(s) or connector(s) is conformal at a level of 500 mm2.

### Claim 17 (depends on 1)

The catheter of claim 1 wherein the hydrophilic polymer layer on an intraluminal surface of a lumen comprised by the catheter body, juncture hub, extension line(s) or connector(s) is conformal at a level of 0.1 mm2.

### Claim 18 (depends on 1)

The catheter of claim 1 wherein the catheter body, juncture hub, extension line(s) or connector(s) have an exterior surface and a hydrophilic polymer layer thereon, the hydrophilic polymer layer having a thickness of at least about 50 nm.

### Claim 19 (depends on 18)

The catheter of claim 18 wherein the hydrophilic polymer layer on the exterior surface of the catheter body, juncture hub, extension line(s) or connector(s) is conformal at a level of 500 mm2.

### Claim 20 (depends on 1)

The catheter of claim 1 wherein the catheter body has a size of 1 French to 16 French.

### Claim 21 (depends on 1)

The catheter of claim 1 wherein the catheter is a hemodialysis catheter, peripherally inserted central catheter, or central venous catheter.

### Claim 22 (depends on 1)

The catheter of claim 1 wherein the catheter body comprises a radiopacifying agent.

### Claim 23 (depends on 1)

The catheter of claim 1 wherein the catheter body comprises bismuth subcarbonate or barium sulfate.

### Claim 24 (depends on 1)

The catheter of claim 1 wherein the hydrophilic polymer layer has a global average dry thickness wherein the standard deviation of the global average dry thickness of the grafted polymer layer does not exceed 100% of the global average dry thickness of the hydrophilic polymer layer.

### Claim 25 (depends on 1)

The catheter of claim 1 wherein the hydrophilic polymer layer and the intraluminal surface or external surface, in combination, constitute a modified surface modified surface having a fibrinogen adsorption of less than about 90 ng/cm2 in a fibrinogen binding assay in which the modified surface is incubated for 60 minutes at 37° C. in a composition containing 70 μg/ml fibrinogen derived from human plasma and 1.4 μg/ml I-125 radiolabeled fibrinogen.

### Claim 26 (depends on 1)

The catheter of claim 1 wherein the hydrophilic polymer is non-fouling.

### Claim 27 (depends on 1)

The catheter of claim 1 wherein the hydrophilic polymer is a zwitterionic polymer.

### Claim 28 (depends on 1)

The catheter of claim 1 wherein the hydrophilic polymer is a carboxybetaine polymer or a sulfobetaine polymer.

### Claim 29 (depends on 1)

The catheter of claim 1 wherein the hydrophilic polymer comprises repeat units at least 30% of which are derived from hydrophilic monomers.

### Claim 30 (depends on 1)

The catheter of claim 1 wherein at least one of the catheter body, juncture hub, extension lines comprises a polyurethane polymer or copolymer.

### Claim 31 (depends on 1)

The catheter of claim 1 wherein the hydrophilic polymer layer and the intraluminal surface or external surface, in combination, constitute a modified surface, the hydrophilic polymer layer has an average dry thickness and a standard deviation of the average dry thickness wherein the standard deviation of the average dry thickness does not exceed 100% of the average dry thickness of the hydrophilic polymer layer.

### Claim 32 (depends on 1)

The catheter of claim 1 wherein the hydrophilic polymer layer has an average dry thickness that is at least equal to the global average Rrms surface roughness of the intraluminal or external surface modified by the hydrophilic polymer layer.

### Claim 33 (depends on 1)

The catheter of claim 1 wherein the hydrophilic polymer comprises repeat units corresponding to Formula 1
wherein
X1 and X2 are independently hydrogen, hydrocarbyl, substituted hydrocarbyl, heterocyclo, or substituted carbonyl, provided, however, X1 and X2 are not each selected from the group consisting of aryl, heteroaryl, and heterosubstituted carbonyl,
X3 is hydrogen, alkyl or substituted alkyl,
X4 is —OX40, —NX41X42, —N+X41X42X43, —SX40, aryl, heteroaryl or acyl,
X40 is hydrogen, hydrocarbyl, substituted hydrocarbyl, heterocyclo or acyl, and
X41, X42 and X43 are independently hydrogen, hydrocaryl, substituted hydrocarbyl or heterocyclo.

### Claim 34 (depends on 1)

The catheter of claim 1 wherein the hydrophilic polymer comprises repeat units corresponding to Formula 3:
wherein X44 comprises an oxylated alkylene moiety, a zwitterionic moiety, an anionic moiety, or a cationic moiety.

### Claim 35 (depends on 1)

The catheter of claim 1 wherein the hydrophilic polymer and the intraluminal surface or exterior surface modified by the hydrophilic polymer, in combination, constitute a modified surface having a fibrinogen adsorption of less than about 20 ng/cm2 in a fibrinogen binding assay in which the modified surface is incubated for 60 minutes at 37° C. in 70 μg/ml fibrinogen derived from human plasma containing 1.4 μg/ml I-125 radiolabeled fibrinogen.

### Claim 36 (depends on 1)

A process for the preparation of a catheter according to claim 1, the process comprising
forming a reaction mixture comprising a hydrophilic monomer, a free radical initiator and a solvent system,
charging the reaction mixture into said catheter body lumen and polymerizing the monomer in the reaction mixture to graft a polymer from the intraluminal surface of said lumen, the reaction mixture having a viscosity of less than 30 cP during polymerization and
continuously or intermittently replacing the reaction mixture charged into said catheter body lumen until the grafted polymer layer has an Average Dry Thickness that exceeds at least about 50 nanometers.
